Embedded Bioprinting of Breast Tumor Cells and Organoids Using Low‐Concentration Collagen‐Based Bioinks
3D bioprinting
Organoid
Fibroin
DOI:
10.1002/adhm.202300905
Publication Date:
2023-07-09T02:30:01Z
AUTHORS (12)
ABSTRACT
Bioinks for 3D bioprinting of tumor models should not only meet printability requirements but also accurately maintain and support phenotypes surrounding cells to recapitulate key hallmarks. Collagen is a major extracellular matrix protein solid tumors, low viscosity collagen solution has made bioprinted cancer challenging. This work produces embedded, breast organoid using low-concentration I based bioinks. The biocompatible physically crosslinked silk fibroin hydrogel used generate the bath embedded printing. composition bioink optimized with thermoresponsive hyaluronic acid-based polymer both noninvasive epithelial invasive cells, as well cancer-associated fibroblasts. Mouse organoids are mimic in vivo morphology. A vascularized model created similar strategy, significantly enhanced vasculature formation under hypoxia. study shows great potential utilizing collagen-based advancing understanding cell biology facilitating drug discovery research.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (95)
CITATIONS (38)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....